LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.11 | 27.76 | 1056 | 3331 | 0.3170 | 0.6935 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.11 | 27.76 | 1115 | 3331 | 0.3347 | 0.7069 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.11 | 27.76 | 1162 | 3331 | 0.3488 | 0.7171 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.81 | 27.76 | 168 | 3596 | 0.0467 | 0.2925 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.81 | 27.76 | 1073 | 3596 | 0.2984 | 0.6834 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.81 | 27.76 | 1139 | 3596 | 0.3167 | 0.6978 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.81 | 27.76 | 1172 | 3596 | 0.3259 | 0.7047 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 44.52 | 27.76 | 174 | 3884 | 0.0448 | 0.2937 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 44.52 | 27.76 | 1121 | 3884 | 0.2886 | 0.6800 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 44.52 | 27.76 | 1117 | 3884 | 0.2876 | 0.6792 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 44.52 | 27.76 | 1149 | 3884 | 0.2958 | 0.6859 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 46.22 | 27.76 | 170 | 4125 | 0.0412 | 0.2855 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 46.22 | 27.76 | 1083 | 4125 | 0.2626 | 0.6616 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 46.22 | 27.76 | 1075 | 4125 | 0.2606 | 0.6599 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 46.22 | 27.76 | 1145 | 4125 | 0.2776 | 0.6745 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 47.93 | 27.76 | 175 | 4421 | 0.0396 | 0.2862 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 47.93 | 27.76 | 1104 | 4421 | 0.2497 | 0.6545 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 47.93 | 27.76 | 1150 | 4421 | 0.2601 | 0.6637 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 47.93 | 27.76 | 1192 | 4421 | 0.2696 | 0.6719 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 49.63 | 27.76 | 183 | 4818 | 0.0380 | 0.2885 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 49.63 | 27.76 | 1080 | 4818 | 0.2242 | 0.6358 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 49.63 | 27.76 | 910 | 4818 | 0.1889 | 0.5986 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 49.63 | 27.76 | 1163 | 4818 | 0.2414 | 0.6522 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 51.33 | 27.76 | 185 | 5117 | 0.0362 | 0.2866 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 51.33 | 27.76 | 1119 | 5117 | 0.2187 | 0.6342 | MN20160318_Q01 | E15 |